Terms: = Liver cancer AND ELK4, SAP1, 2005, ENSG00000158711, P28324 AND Prognosis
366 results:
1. The Albumin-bilirubin Grade as Prognostic Indicator for Recurrent Hepatocellular Carcinoma Needing Repeat liver Resection.
Gon H; Komatsu S; Omiya S; Kido M; Fukushima K; Urade T; Yoshida T; Arai K; Ishida J; Nanno Y; Tsugawa D; Yanagimoto H; Toyama H; Fukumoto T
Anticancer Res; 2024 May; 44(5):2031-2038. PubMed ID: 38677757
[TBL] [Abstract] [Full Text] [Related]
2. [Surgical treatment and prognosis analysis of hilar cholangiocarcinoma].
Li XC; Li CX; Zhang H; Cheng F; Zhang F; Pu LY; Zhang CY; Wang K; Kong LB; Qian XF; Li DH; Lu WX; Wang P; Yao AH; Bai JF; Wu XF; Chen RX; Wang XH
Zhonghua Wai Ke Za Zhi; 2024 Apr; 62(4):290-301. PubMed ID: 38432670
[No Abstract] [Full Text] [Related]
3. Clinical Impact of Conversion Surgery After Induction Therapy for Esophageal cancer with Synchronous Distant Metastasis: A Multi-institutional Retrospective Study.
Sugimura K; Tanaka K; Sugase T; Momose K; Kanemura T; Yamashita K; Makino T; Shiraishi O; Motoori M; Yamasaki M; Miyata H; Fujitani K; Yasuda T; Yano M; Eguchi H; Doki Y
Ann Surg Oncol; 2024 May; 31(5):3437-3447. PubMed ID: 38300405
[TBL] [Abstract] [Full Text] [Related]
4. Reappraisal of Portal Vein Tumor Thrombosis as a Prognostic Factor for Patients with Hepatocellular Carcinoma.
Chang Y; Yu SJ; Kim HC; Lee YB; Cho EJ; Lee JH; Kim YJ; Chung JW; Yoon JH
Gut Liver; 2024 Jan; 18(1):156-164. PubMed ID: 38013475
[TBL] [Abstract] [Full Text] [Related]
5. Impact of multimorbidity and polypharmacy on mortality after cancer: a nationwide registry-based cohort study in Denmark 2005-2017.
Thomsen MK; Løppenthin KB; Bidstrup PE; Andersen EW; Dalton S; Petersen LN; Pappot H; Mortensen CE; Christensen MB; Frølich A; Lassen U; Johansen C
Acta Oncol; 2023 Dec; 62(12):1653-1660. PubMed ID: 37874076
[TBL] [Abstract] [Full Text] [Related]
6. External validation of subclassification system and progression pattern analysis in hepatocelluar carcinoma with macroscopic vascular invasion.
Yu JI; Park HC; Shin H; Park H; Shin SW; Cho SK; Hyun D; Shin J; Goh MJ; Choi MS; Park B; Yoon SM; Jung J
Radiother Oncol; 2023 Oct; 187():109841. PubMed ID: 37543052
[TBL] [Abstract] [Full Text] [Related]
7. Clinical impact of hepatic steatosis on chronic hepatitis B patients in Asia: A systematic review and meta-analysis.
Zhou R; Yang L; Zhang B; Gu Y; Kong T; Zhang W; Sun L; Liu C; Kong N; Li J; Shi J
J Viral Hepat; 2023 Oct; 30(10):793-802. PubMed ID: 37533208
[TBL] [Abstract] [Full Text] [Related]
8. Artificial intelligence-based reticulin proportionate area - a novel histological outcome predictor in hepatocellular carcinoma.
Patil A; Salvatori R; Smith L; Jenkins SM; Cannon A; Hartley CP; Graham RP; Moreira RK
Histopathology; 2023 Oct; 83(4):512-525. PubMed ID: 37387193
[TBL] [Abstract] [Full Text] [Related]
9. Prediction of regional lymph node metastasis in intrahepatic cholangiocarcinoma: it's not all about size.
Kolck J; Auer TA; Walter-Rittel T; Hosse C; Elkilany A; Marth AA; Pelzer U; Mohr R; Krenzien F; Lurje G; Schöning W; Hamm B; Geisel D; Fehrenbach U
Abdom Radiol (NY); 2023 Oct; 48(10):3063-3071. PubMed ID: 37354262
[TBL] [Abstract] [Full Text] [Related]
10. prognosis of spontaneously ruptured hepatocellular carcinoma: a propensity score matching study.
Zhang SY; Guo DZ; Zhang X; Fan J; Zhou J; Huang A
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8889-8896. PubMed ID: 37154926
[TBL] [Abstract] [Full Text] [Related]
11. Primary and secondary angiosarcomas of the liver: a multi-institutional study of 32 cases.
Liao X; Lai J; Lin J; Zhang D
Hum Pathol; 2023 Jul; 137():10-17. PubMed ID: 37054784
[TBL] [Abstract] [Full Text] [Related]
12. The care cascade for hepatitis C virus and prognosis of chronic hepatitis C patients treated with antiviral agents in a tertiary hospital.
Yoo SH; Kim M; Kim S; Lee JI; Lee KS; Lee HW; Lim JH
BMC Gastroenterol; 2023 Apr; 23(1):116. PubMed ID: 37041473
[TBL] [Abstract] [Full Text] [Related]
13. Effect of vessels that encapsulate tumor clusters (VETC) on the prognosis of different stages of hepatocellular carcinoma after hepatectomy.
Wang YY; Dong K; Wang K; Sun Y; Xing BC
Dig Liver Dis; 2023 Sep; 55(9):1288-1294. PubMed ID: 37037766
[TBL] [Abstract] [Full Text] [Related]
14. Recurrence of hepatocellular carcinoma in noncirrhotic patients with nonalcoholic fatty liver disease versus hepatitis B infection.
Lee J; Chang JI; Jin YJ; Lee JH; Kim JY; Sinn DH; Kim SS; Lee HW; Yoo SH; Yu JH; Lee JW
Eur J Gastroenterol Hepatol; 2023 Apr; 35(4):431-439. PubMed ID: 36728881
[TBL] [Abstract] [Full Text] [Related]
15. The impact of the advanced lung cancer inflammation index on the outcomes of patients with metastatic colorectal cancer who receive chemotherapy.
Horino T; Tokunaga R; Miyamoto Y; Hiyoshi Y; Akiyama T; Daitoku N; Sakamoto Y; Yoshida N; Baba H
Int J Clin Oncol; 2023 Mar; 28(3):400-408. PubMed ID: 36637609
[TBL] [Abstract] [Full Text] [Related]
16. Preoperative transcatheter arterial chemoembolization and prognosis of patients with solitary large hepatocellular carcinomas (≥5 cm): Multicenter retrospective study.
Mo A; Zhang Q; Xia F; Huang Z; Peng S; Cao W; Mei H; Ren L; Su Y; Gao H; Chen W
Cancer Med; 2023 Apr; 12(7):7734-7747. PubMed ID: 36540041
[TBL] [Abstract] [Full Text] [Related]
17. Statin use is associated with better post-operative prognosis among patients with hepatitis B virus-related hepatocellular carcinoma.
Yun B; Ahn SH; Oh J; Yoon JH; Kim BK
Eur J Clin Invest; 2023 Apr; 53(4):e13936. PubMed ID: 36504405
[TBL] [Abstract] [Full Text] [Related]
18. Colonization with multidrug-resistant organisms is associated with impaired survival of patients with surgically resected cholangiocarcinoma.
Kinzler MN; Stehle A; Schulze F; Hogardt M; Wichelhaus TA; Kempf VAJ; Finkelmeier F; Trojan J; Zeuzem S; Schnitzbauer AA; Bechstein WO; Wild PJ; Walter D
Liver Int; 2023 Feb; 43(2):490-499. PubMed ID: 36424731
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic analysis of patients with combined hepatocellular-cholangiocarcinoma after radical resection: A retrospective multicenter cohort study.
Zhang G; Chen BW; Yang XB; Wang HY; Yang X; Xie FC; Chen XQ; Yu LX; Shi J; Lu YY; Zhao HT
World J Gastroenterol; 2022 Nov; 28(41):5968-5981. PubMed ID: 36405111
[TBL] [Abstract] [Full Text] [Related]
20. Antineoplastic chemotherapy and immunosuppression in liver transplant recipients: Squaring the circle?
Coupier A; Gallien Y; Boillot O; Walter T; Guillaud O; Vallin M; Thimonier E; Erard D; Dumortier J
Clin Transplant; 2023 Jan; 37(1):e14841. PubMed ID: 36394373
[TBL] [Abstract] [Full Text] [Related]
[Next]
